Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

44.84
-2.4100-5.10%
Post-market: 44.900.0600+0.13%16:34 EDT
Volume:7.62M
Turnover:348.69M
Market Cap:7.45B
PE:-12.89
High:47.59
Open:47.38
Low:44.66
Close:47.25
52wk High:86.74
52wk Low:44.66
Shares:166.18M
Float Shares:161.92M
Volume Ratio:1.81
T/O Rate:4.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:16.95
PE(LYR):-18.83

Loading ...

Ionis Director Michael R. Hayden Reports Acquisition of 20,000 Common Shares Worth $1,059,000

Reuters
·
Aug 01

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Benzinga Earnings
·
Jul 31

Ionis Pharmaceuticals: Strong Commercial Momentum and Late‑Stage Pipeline Catalysts Drive Buy Rating

TIPRANKS
·
Jul 31

Ionis Pharmaceuticals is Maintained at Overweight by Wells Fargo

Dow Jones
·
Jul 30

Alnylam Q2 Revenue Rises 67% on Increased Demand for Amvuttra

Reuters
·
Jul 30

RBC Capital Reaffirms Their Buy Rating on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Jul 30

Ionis Pharmaceuticals price target lowered to $115 from $125 at H.C. Wainwright

TIPRANKS
·
Jul 30

Ionis Pharmaceuticals price target raised to $69 from $66 at Goldman Sachs

TIPRANKS
·
Jul 30

Viking Therapeutics Reports Q2 Milder-than-expected Net Loss as Obesity Trials Advance

Reuters
·
Jul 30

Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio

Benzinga Earnings
·
Jul 30

Ionis Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Analysts Are Bullish on Top Healthcare Stocks: Option Care Health (OPCH), Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Jul 29

Ionis Q2 Adjusted Operating Loss Narrows

Reuters
·
Jul 29

Earnings Flash (IONS) Ionis Pharmaceuticals Posts Q2 Loss $0.69 a Share, vs. FactSet Est of $1.08 Loss

MT Newswires Live
·
Jul 29

Ionis Q2 FY26 Revenue Drops 40.71% to $268 Million; Operating Loss Widens to $102 Million

Reuters
·
Jul 29

Ionis Announces DR. Frank Bennett, Chief Scientific Officer, to Retire

THOMSON REUTERS
·
Jul 29

Ionis Pharmaceuticals Q2 Adj. EPS $(0.42) Beats $(1.07) Estimate, Sales $268.000M Beat $190.670M Estimate

Benzinga Earnings
·
Jul 29

Ionis Pharmaceuticals Q2 Adjusted Operating Expenses USD 325 Million

THOMSON REUTERS
·
Jul 29

Corrected-Ionis Pharmaceuticals Q2 Net Income USD -115 Million (Corrects Amount)

THOMSON REUTERS
·
Jul 29

Ionis Pharmaceuticals Inc: on Track to Achieve 2026 Financial Guidance

THOMSON REUTERS
·
Jul 29